Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immunomodulators for multiple sclerosis may ameliorate spinal bone loss.
Value of NMO-IgG determination at the time of presentation as CIS.
Proceedings of the European Charcot Foundation Symposium A Reappraisal of Nutrition and Environment in Multiple Sclerosis, European Charcot Foundation Symposium, December 2-4, 2010, Fiuggi, Italy.
Compressive syndrome of internal jugular veins in multiple sclerosis: does it matter?
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
Compressive myelopathy: magnetic resonance imaging findings simulating idiopathic acute transverse myelopathy.
Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis.
Generation of oligodendroglial cells by direct lineage conversion.
Vitamin D and multiple sclerosis: where do we go from here?
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action.
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors.
The gut microbiome in multiple sclerosis.
Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis.
Compassionate Use Programme Update
Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.

Pages